Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Spag16 | Rat | (-)-epigallocatechin 3-gallate | multiple interactions | ISO | SPAG16 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SPAG16 mRNA | CTD | PMID:22079256 | Spag16 | Rat | 1,2-dichloroethane | decreases expression | ISO | Spag16 (Mus musculus) | 6480464 | ethylene dichloride results in decreased expression of SPAG16 mRNA | CTD | PMID:28960355 | Spag16 | Rat | 17beta-estradiol | decreases expression | ISO | SPAG16 (Homo sapiens) | 6480464 | Estradiol results in decreased expression of SPAG16 mRNA | CTD | PMID:23019147 | Spag16 | Rat | 17beta-estradiol | affects expression | ISO | SPAG16 (Homo sapiens) | 6480464 | Estradiol affects the expression of SPAG16 mRNA | CTD | PMID:22574217 | Spag16 | Rat | 2,3',4,4',5-Pentachlorobiphenyl | increases expression | ISO | Spag16 (Mus musculus) | 6480464 | 2,3',4,4',5-pentachlorobiphenyl results in increased expression of SPAG16 mRNA | CTD | PMID:31388691 | Spag16 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Spag16 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of SPAG16 mRNA | CTD | PMID:21570461 | Spag16 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Spag16 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of SPAG16 mRNA | CTD | PMID:33956508 | Spag16 | Rat | 6-propyl-2-thiouracil | increases expression | EXP | | 6480464 | Propylthiouracil results in increased expression of SPAG16 mRNA | CTD | PMID:24780913 | Spag16 | Rat | acrylamide | decreases expression | ISO | SPAG16 (Homo sapiens) | 6480464 | Acrylamide results in decreased expression of SPAG16 mRNA | CTD | PMID:32763439 | Spag16 | Rat | aflatoxin B1 | decreases methylation | ISO | SPAG16 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased methylation of SPAG16 gene | CTD | PMID:27153756 | Spag16 | Rat | aflatoxin B1 | increases methylation | ISO | SPAG16 (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased methylation of SPAG16 intron | CTD | PMID:30157460 | Spag16 | Rat | aflatoxin M1 | decreases expression | ISO | SPAG16 (Homo sapiens) | 6480464 | Aflatoxin M1 results in decreased expression of SPAG16 mRNA | CTD | PMID:30928695 | Spag16 | Rat | antirheumatic drug | increases expression | ISO | SPAG16 (Homo sapiens) | 6480464 | Antirheumatic Agents results in increased expression of SPAG16 mRNA | CTD | PMID:24449571 | Spag16 | Rat | arsenite(3-) | increases methylation | ISO | SPAG16 (Homo sapiens) | 6480464 | arsenite results in increased methylation of SPAG16 promoter | CTD | PMID:23974009 | Spag16 | Rat | benzo[a]pyrene | increases mutagenesis | ISO | SPAG16 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased mutagenesis of SPAG16 gene | CTD | PMID:25435355 | Spag16 | Rat | benzo[a]pyrene | decreases methylation | ISO | Spag16 (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased methylation of SPAG16 intron | CTD | PMID:27901495 | Spag16 | Rat | benzo[a]pyrene | increases methylation | ISO | SPAG16 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of SPAG16 3' UTR | CTD | PMID:27901495 | Spag16 | Rat | benzo[a]pyrene | increases expression | ISO | Spag16 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of SPAG16 mRNA | CTD | PMID:27195522 | Spag16 | Rat | benzo[e]pyrene | increases methylation | ISO | SPAG16 (Homo sapiens) | 6480464 | benzo(e)pyrene results in increased methylation of SPAG16 intron | CTD | PMID:30157460 | Spag16 | Rat | beta-hexachlorocyclohexane | increases expression | ISO | Spag16 (Mus musculus) | 6480464 | beta-hexachlorocyclohexane results in increased expression of SPAG16 mRNA | CTD | PMID:25270620 | Spag16 | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of SPAG16 mRNA | CTD | PMID:25181051|PMID:34947998 | Spag16 | Rat | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of SPAG16 gene | CTD | PMID:28505145 | Spag16 | Rat | cadmium atom | multiple interactions | EXP | | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SPAG16 more ... | CTD | PMID:39012411 | Spag16 | Rat | cadmium dichloride | multiple interactions | EXP | | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SPAG16 more ... | CTD | PMID:39012411 | Spag16 | Rat | carbon nanotube | decreases expression | ISO | Spag16 (Mus musculus) | 6480464 | Nanotubes, Carbon analog results in decreased expression of SPAG16 mRNA; Nanotubes, Carbon results in decreased more ... | CTD | PMID:25554681 | Spag16 | Rat | CGP 52608 | multiple interactions | ISO | SPAG16 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to SPAG16 gene] | CTD | PMID:28238834 | Spag16 | Rat | cisplatin | decreases expression | ISO | SPAG16 (Homo sapiens) | 6480464 | Cisplatin results in decreased expression of SPAG16 mRNA | CTD | PMID:27392435 | Spag16 | Rat | copper atom | increases expression | EXP | | 6480464 | Copper deficiency results in increased expression of SPAG16 mRNA | CTD | PMID:26033743 | Spag16 | Rat | copper atom | multiple interactions | EXP | | 6480464 | [Copper co-treated with Dietary Sucrose] results in increased expression of SPAG16 mRNA | CTD | PMID:26033743 | Spag16 | Rat | copper(0) | multiple interactions | EXP | | 6480464 | [Copper co-treated with Dietary Sucrose] results in increased expression of SPAG16 mRNA | CTD | PMID:26033743 | Spag16 | Rat | copper(0) | increases expression | EXP | | 6480464 | Copper deficiency results in increased expression of SPAG16 mRNA | CTD | PMID:26033743 | Spag16 | Rat | copper(II) sulfate | decreases expression | ISO | SPAG16 (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of SPAG16 mRNA | CTD | PMID:19549813 | Spag16 | Rat | cyclosporin A | decreases expression | ISO | SPAG16 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of SPAG16 mRNA | CTD | PMID:25562108 | Spag16 | Rat | cytarabine | increases expression | ISO | SPAG16 (Homo sapiens) | 6480464 | Cytarabine results in increased expression of SPAG16 mRNA | CTD | PMID:21198554 | Spag16 | Rat | dicrotophos | decreases expression | ISO | SPAG16 (Homo sapiens) | 6480464 | dicrotophos results in decreased expression of SPAG16 mRNA | CTD | PMID:28302478 | Spag16 | Rat | folic acid | increases expression | ISO | Spag16 (Mus musculus) | 6480464 | Folic Acid results in increased expression of SPAG16 mRNA | CTD | PMID:25629700 | Spag16 | Rat | genistein | decreases expression | ISO | SPAG16 (Homo sapiens) | 6480464 | Genistein results in decreased expression of SPAG16 mRNA | CTD | PMID:23019147 | Spag16 | Rat | glufosinate | decreases expression | ISO | Spag16 (Mus musculus) | 6480464 | phosphinothricin results in decreased expression of SPAG16 mRNA | CTD | PMID:34597628 | Spag16 | Rat | lead diacetate | multiple interactions | ISO | Spag16 (Mus musculus) | 6480464 | [lead acetate results in increased abundance of Lead] which results in decreased methylation of SPAG16 more ... | CTD | PMID:33445541 | Spag16 | Rat | lead(0) | multiple interactions | ISO | Spag16 (Mus musculus) | 6480464 | [lead acetate results in increased abundance of Lead] which results in decreased methylation of SPAG16 more ... | CTD | PMID:33445541 | Spag16 | Rat | lipopolysaccharide | multiple interactions | ISO | SPAG16 (Homo sapiens) | 6480464 | [S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of SPAG16 mRNA | CTD | PMID:35811015 | Spag16 | Rat | methapyrilene | increases methylation | ISO | SPAG16 (Homo sapiens) | 6480464 | Methapyrilene results in increased methylation of SPAG16 intron | CTD | PMID:30157460 | Spag16 | Rat | N-acetyl-1,4-benzoquinone imine | affects response to substance | ISO | SPAG16 (Homo sapiens) | 6480464 | SPAG16 gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine | CTD | PMID:21177773 | Spag16 | Rat | okadaic acid | decreases expression | ISO | SPAG16 (Homo sapiens) | 6480464 | Okadaic Acid results in decreased expression of SPAG16 mRNA | CTD | PMID:38832940 | Spag16 | Rat | paracetamol | decreases expression | ISO | SPAG16 (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of SPAG16 mRNA | CTD | PMID:26690555 | Spag16 | Rat | phenobarbital | affects expression | ISO | SPAG16 (Homo sapiens) | 6480464 | Phenobarbital affects the expression of SPAG16 mRNA | CTD | PMID:19159669 | Spag16 | Rat | potassium chromate | decreases expression | ISO | SPAG16 (Homo sapiens) | 6480464 | potassium chromate(VI) results in decreased expression of SPAG16 mRNA | CTD | PMID:22079256 | Spag16 | Rat | potassium chromate | multiple interactions | ISO | SPAG16 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SPAG16 mRNA | CTD | PMID:22079256 | Spag16 | Rat | quercetin | decreases expression | ISO | SPAG16 (Homo sapiens) | 6480464 | Quercetin results in decreased expression of SPAG16 mRNA | CTD | PMID:21632981 | Spag16 | Rat | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | ISO | SPAG16 (Homo sapiens) | 6480464 | [S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of SPAG16 mRNA | CTD | PMID:35811015 | Spag16 | Rat | titanium dioxide | decreases expression | ISO | Spag16 (Mus musculus) | 6480464 | titanium dioxide results in decreased expression of SPAG16 mRNA | CTD | PMID:23557971 | Spag16 | Rat | triphenyl phosphate | affects expression | ISO | SPAG16 (Homo sapiens) | 6480464 | triphenyl phosphate affects the expression of SPAG16 mRNA | CTD | PMID:37042841 | Spag16 | Rat | vinclozolin | increases methylation | EXP | | 6480464 | vinclozolin results in increased methylation of SPAG16 gene | CTD | PMID:31079544 | | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||






















